
Roivant Sciences Ltd.: updates and filings
Price
$38.66
November 20, 2026Market cap $27.8B
What Ploutos Investor adds for Roivant Sciences
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from FY2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 9, 2026next Feb 8, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
September 2026
August 2026
May 2026
March 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 13, 2026Filing (amendment)Form144/A
- Nov 13, 2026Filing (amendment)Form144/A
- Nov 10, 2026Filing (amendment)Form144/A
- Nov 10, 2026Filing (amendment)Form144/A
- Nov 10, 2026Filing (amendment)Form144/A
- Nov 9, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 9, 2026Results of operationsForm8-K
- Nov 5, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 21, 2026Regulation FD disclosureForm8-K
- Oct 5, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Sep 18, 2026Shareholder voteForm8-K
- Sep 8, 2026Regulation FD disclosureForm8-K
- Aug 28, 2026Other material eventsForm8-K
- Aug 27, 2026Regulation FD disclosureForm8-K
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jul 29, 2026Annual report to shareholdersfor the period to Mar 31, 2026FormARS
- Jul 29, 2026Additional annual meeting materialFormDEFA14A
- Jul 29, 2026Annual meeting proxy statementFormDEF 14A
- May 20, 2026Shares registered for employeesFormS-8
- May 20, 2026Annual reportfor the period to Mar 31, 2026Form10-K
- May 20, 2026Results of operationsForm8-K
- May 12, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 13, 2026 | 144/A | Filing (amendment) | Document |
| Nov 13, 2026 | 144/A | Filing (amendment) | Document |
| Nov 10, 2026 | 144/A | Filing (amendment) | Document |
| Nov 10, 2026 | 144/A | Filing (amendment) | Document |
| Nov 10, 2026 | 144/A | Filing (amendment) | Document |
| Nov 9, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 9, 2026 | 8-K | Results of operations | Document |
| Nov 5, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 21, 2026 | 8-K | Regulation FD disclosure | Document |
| Oct 5, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Sep 18, 2026 | 8-K | Shareholder vote | Document |
| Sep 8, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 28, 2026 | 8-K | Other material events | Document |
| Aug 27, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jul 29, 2026 | ARS | Annual report to shareholdersfor the period to Mar 31, 2026 | Document |
| Jul 29, 2026 | DEFA14A | Additional annual meeting material | Document |
| Jul 29, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| May 20, 2026 | S-8 | Shares registered for employees | Document |
| May 20, 2026 | 10-K | Annual reportfor the period to Mar 31, 2026 | Document |
| May 20, 2026 | 8-K | Results of operations | Document |
| May 12, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jun 10, 2015.
The full analysis
What do Roivant Sciences's filings show?
The filings are where every one of Roivant Sciences's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.